Related Experiment Video
Updated: Mar 19, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Multiple Targeting Approaches on Histamine H3 Receptor Antagonists
Mohammad A Khanfar1, Anna Affini2, Kiril Lutsenko2
1Stark Lab, Institut fuer Pharmazeutische and Medizinische Chemie, Heinrich-Heine-Universitaet DuesseldorfDuesseldorf, Germany; Faculty of Pharmacy, The University of JordanAmman, Jordan.
Novel multifunctional histamine H3 receptor antagonists are gaining interest, especially after pitolisant (Wakix®) market approval. These compounds offer improved effects and reduced side-effects through polypharmacology, targeting various receptors and signaling pathways.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Recent market approval of pitolisant (Wakix®) has increased interest in histamine H3 receptor antagonists.
- Histamine H3 receptor antagonists are being investigated for diverse clinical indications.
- Understanding complex neurotransmitter regulations supports the development of multifunctional drugs.
Purpose of the Study:
- To explore the clinical applications of novel multifunctional histamine H3 receptor antagonists.
- To describe polypharmacological approaches for histamine H3 receptor antagonists.
- To present lead structures for improved pharmacological effects and reduced side-effects.
Main Methods:
- Review of clinical development of histamine H3 receptor antagonists.
- Analysis of polypharmacological strategies targeting G-protein coupled receptors, transporters, and enzymes.
- Investigation of effects on NO-signaling mechanisms.
Main Results:
- Increased interest in multifunctional histamine H3 receptor antagonists due to pitolisant's approval.
- Rationale for combining pharmacological properties in single molecules for enhanced efficacy and safety.
- Description of polypharmacological approaches and supporting lead structures.
Conclusions:
- Multifunctional histamine H3 receptor antagonists represent a promising therapeutic strategy.
- Polypharmacology allows for tailored drug design to optimize therapeutic outcomes.
- Further development of these agents is supported by current scientific knowledge.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

